Literature DB >> 10663217

Both insulin sensitivity and insulin clearance in children and young adults with type I (insulin-dependent) diabetes vary with growth hormone concentrations and with age.

C L Acerini1, T D Cheetham, J A Edge, D B Dunger.   

Abstract

AIMS/HYPOTHESIS: We measured insulin clearance rates in children and young adults with Type I (insulin-dependent) diabetes mellitus to establish their relation with insulin sensitivity and with factors such as growth hormone secretion and body mass index.
METHODS: We studied 46 subjects mean (range) age 14.4 (9.8-24.6) years), body mass index 21.1 (15.8-29.6) Kgm2[ using an overnight (1800-0800 hours) variable rate insulin infusion euglycaemic clamp protocol (5 mmol/l). Plasma free insulin concentrations during steady-state euglycaemia were used as an index of insulin sensitivity and insulin clearance determined as a ratio of insulin infusion rate to plasma free insulin.
RESULTS: During steady-state euglycaemia (0500-0730 hours), insulin sensitivity mean (SEM) plasma insulin 0.020 (0.002) mU/l[ and insulin clearance rates 19.1 (1.8) ml.kg-1.min[ varied with age non-linearly and in a reciprocal fashion to each other (cubic regression F = 4.09, p = 0.01; F = 3.55, p = 0.02, respectively). Insulin sensitivity was negatively related to BMI (r = -0.37, p = 0.011) and mean overnight growth hormone concentrations (r = -0.40, p = 0.007). Insulin clearance was only related to growth hormone concentrations (r = -0.37, p = 0.014). These relations were still evident after stepwise multiple regression analysis (potential determinants: C peptide, sex, age, puberty stage, HbA1c, duration of diabetes): insulin sensitivity r = 0.55, p < 0.001; insulin clearance r = 0.37, p < 0.02. CONCLUSIONS/
INTERPRETATION: Insulin clearance rates vary with age in young subjects with Type I diabetes and are highest during mid-adolescence when insulin sensitivity is at its lowest. Both insulin sensitivity and insulin clearance are related to circulating growth hormone concentrations.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10663217     DOI: 10.1007/s001250050008

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  13 in total

1.  Developing multi-faith chaplaincy.

Authors:  A R Gatrad; E Brown; A Sheikh
Journal:  Arch Dis Child       Date:  2004-06       Impact factor: 3.791

Review 2.  New developments in the treatment of type 1 diabetes in children.

Authors:  Thomas Danne; Karin Lange; Olga Kordonouri
Journal:  Arch Dis Child       Date:  2007-11       Impact factor: 3.791

3.  Predictors of changing insulin dose requirements and glycaemic control in children, adolescents and young adults with Type 1 diabetes.

Authors:  G H Teló; C E Dougher; L K Volkening; M L Katz; L M Laffel
Journal:  Diabet Med       Date:  2018-06-19       Impact factor: 4.359

4.  The diabetes-susceptible gene SLC30A8/ZnT8 regulates hepatic insulin clearance.

Authors:  Motoyuki Tamaki; Yoshio Fujitani; Akemi Hara; Toyoyoshi Uchida; Yoshifumi Tamura; Kageumi Takeno; Minako Kawaguchi; Takahiro Watanabe; Takeshi Ogihara; Ayako Fukunaka; Tomoaki Shimizu; Tomoya Mita; Akio Kanazawa; Mica O Imaizumi; Takaya Abe; Hiroshi Kiyonari; Shintaro Hojyo; Toshiyuki Fukada; Takeshi Kawauchi; Shinya Nagamatsu; Toshio Hirano; Ryuzo Kawamori; Hirotaka Watada
Journal:  J Clin Invest       Date:  2013-09-24       Impact factor: 14.808

5.  Improved insulin sensitivity, preserved beta cell function and improved whole-body glucose metabolism after low-dose growth hormone replacement therapy in adults with severe growth hormone deficiency: a pilot study.

Authors:  A M Arafat; M Möhlig; M O Weickert; C Schöfl; J Spranger; A F H Pfeiffer
Journal:  Diabetologia       Date:  2010-04-06       Impact factor: 10.122

6.  Glycemic control and variability in association with body mass index and body composition over 18months in youth with type 1 diabetes.

Authors:  Leah M Lipsky; Benjamin Gee; Aiyi Liu; Tonja R Nansel
Journal:  Diabetes Res Clin Pract       Date:  2016-08-06       Impact factor: 5.602

7.  Prognostic performance of metabolic indexes in predicting onset of type 1 diabetes.

Authors:  Ping Xu; Yougui Wu; Yiliang Zhu; Getachew Dagne; Giffe Johnson; David Cuthbertson; Jeffrey P Krischer; Jay M Sosenko; Jay S Skyler
Journal:  Diabetes Care       Date:  2010-08-31       Impact factor: 19.112

8.  Metabolic control as reflected by HbA1c in children, adolescents and young adults with type-1 diabetes mellitus: combined longitudinal analysis including 27,035 patients from 207 centers in Germany and Austria during the last decade.

Authors:  E-M Gerstl; W Rabl; J Rosenbauer; H Gröbe; S E Hofer; U Krause; R W Holl
Journal:  Eur J Pediatr       Date:  2007-10-09       Impact factor: 3.183

9.  The effects of a specific growth hormone antagonist on overnight insulin requirements and insulin sensitivity in young adults with Type 1 diabetes mellitus.

Authors:  R M Williams; R Amin; F Shojaee-Moradie; A M Umpleby; C L Acerini; D B Dunger
Journal:  Diabetologia       Date:  2003-07-24       Impact factor: 10.122

10.  Establishing glycaemic control with continuous subcutaneous insulin infusion in children and adolescents with type 1 diabetes: experience of the PedPump Study in 17 countries.

Authors:  T Danne; T Battelino; P Jarosz-Chobot; O Kordonouri; E Pánkowska; J Ludvigsson; E Schober; E Kaprio; T Saukkonen; M Nicolino; N Tubiana-Rufi; C Klinkert; H Haberland; A Vazeou; L Madacsy; D Zangen; V Cherubini; I Rabbone; S Toni; C de Beaufort; W Bakker-van Waarde; N van den Berg; I Volkov; R Barrio; R Hanas; U Zumsteg; B Kuhlmann; C Aebi; U Schumacher; S Gschwend; P Hindmarsh; M Torres; N Shehadeh; M Phillip
Journal:  Diabetologia       Date:  2008-07-01       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.